|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the MEDTAP International, Inc, Bethesda, MD
2 From the Johns Hopkins Asthma and Allergy Center, Baltimore, MD.
Dennis Revicki, PhD, Center for Health Outcomes Research, MEDTAP International, Inc, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, e-mail: Revicki{at}Medtap.com
Study objective: To develop and evaluate a brief, easy-to-administer symptom assessment scale for use as a preference-based outcome measure in clinical trials and cost-effectiveness studies in asthma.
Design: Cross-sectional survey with 2-week reproducibility assessment.
Setting: Ambulatory care: university asthma and allergy center.
Participants: One hundred sixty-one adults with asthma, 59% female, mean age 35 ± 11 years. Mean FEV1 percent predicted was 86 ± 17%.
Interventions: The 11-item Asthma Symptom Utility Index (ASUI).
Measurements and results: Mean ASUI score for this sample was 0.71 ± 0.23, with a range from 0.02 to 1.0. The ASUI was reproducible (intraclass correlation coefficient = 0.74) and able to distinguish patients known to differ on disease severity according to clinician ratings (p < 0.001) and by an asthma disease severity scale score (p < 0.001). The instrument was also significantly correlated with FEV1 percent predicted (r = 0.27, p < 0.001), the Asthma Quality of Life Questionnaire (r = 0.77, p < 0.001), and the Health Utilities Index Mark 2 (r = 0.36, p < 0.001).
Conclusion: The results of this study support the reliability and validity of the ASUI, suggesting it will be a useful, complementary patient outcome measure for clinical trials and cost-effectiveness studies comparing treatment alternatives for persons with asthma.
Key Words: asthma-related symptoms health preferences quality of life patient outcomes
Submitted on November 3, 1997
Accepted on May 7, 1998
This article has been cited by other articles:
![]() |
J. Simpkins, G. Divine, M. Wang, E. Holmboe, M. Pladevall, and L. K. Williams Improving Asthma Care Through Recertification: A Cluster Randomized Trial Arch Intern Med, November 12, 2007; 167(20): 2240 - 2248. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Dixon, D. A. Kaminsky, J. T. Holbrook, R. A. Wise, D. M. Shade, and C. G. Irvin Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest, August 1, 2006; 130(2): 429 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Yawn, S. K. Brenneman, F. C. Allen-Ramey, M. D. Cabana, and L. E. Markson Assessment of Asthma Severity and Asthma Control in Children Pediatrics, July 1, 2006; 118(1): 322 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lima, S. Zhang, A. Grant, L. Shao, K. G. Tantisira, H. Allayee, J. Wang, J. Sylvester, J. Holbrook, R. Wise, et al. Influence of Leukotriene Pathway Polymorphisms on Response to Montelukast in Asthma Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 379 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Zeidler, E. C. Kleerup, J. G. Goldin, H. J. Kim, D. A. Truong, M. D. Simmons, J. W. Sayre, W. Liu, R. Elashoff, and D. P. Tashkin Montelukast improves regional air-trapping due to small airways obstruction in asthma Eur. Respir. J., February 1, 2006; 27(2): 307 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Boushey, C. A. Sorkness, T. S. King, S. D. Sullivan, J. V. Fahy, S. C. Lazarus, V. M. Chinchilli, T. J. Craig, E. A. Dimango, A. Deykin, et al. Daily versus As-Needed Corticosteroids for Mild Persistent Asthma N. Engl. J. Med., April 14, 2005; 352(15): 1519 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Sharek, M. L. Mayer, L. Loewy, T. N. Robinson, R. S. Shames, D. T. Umetsu, and D. A. Bergman Agreement Among Measures of Asthma Status: A Prospective Study of Low-Income Children With Moderate to Severe Asthma Pediatrics, October 1, 2002; 110(4): 797 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
The American Lung Association Asthma Clinical Rese The Safety of Inactivated Influenza Vaccine in Adults and Children with Asthma N. Engl. J. Med., November 22, 2001; 345(21): 1529 - 1536. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |